{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:09:03Z","timestamp":1761293343779,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81502993"],"award-info":[{"award-number":["81502993"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s12272-015-0685-5","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T09:39:56Z","timestamp":1447925996000},"page":"202-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Formulation of nimodipine nanocrystals for oral administration"],"prefix":"10.1007","volume":"39","author":[{"given":"Jianwen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,19]]},"reference":[{"key":"685_CR1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijpharm.2014.12.003","volume":"478","author":"BK Ahuja","year":"2015","unstructured":"Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S (2015) Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Int J Pharm 478:540\u2013552","journal-title":"Int J Pharm"},{"key":"685_CR2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijbiomac.2014.03.006","volume":"67","author":"IH Baek","year":"2014","unstructured":"Baek IH, Kim JS, Ha ES, Choo GH, Cho W, Hwang SJ, Kim MS (2014) Dissolution and oral absorption of pranlukast nanosuspensions stabilized by hydroxypropylmethyl cellulose. Int J Biol Macromol 67:53\u201357","journal-title":"Int J Biol Macromol"},{"key":"685_CR3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejps.2012.04.020","volume":"47","author":"S Bose","year":"2012","unstructured":"Bose S, Schenck D, Ghosh I, Hollywood A, Maulit E, Ruegger C (2012) Application of spray granulation for conversion of a nanosuspension into a dry powder form. Eur J Pharm Sci 47:35\u201343","journal-title":"Eur J Pharm Sci"},{"key":"685_CR4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2012.11.044","volume":"443","author":"AM Cerdeira","year":"2013","unstructured":"Cerdeira AM, Mazzotti M, Gander B (2013) Formulation and drying of miconazole and itraconazole nanosuspensions. Int J Pharm 443:209\u2013220","journal-title":"Int J Pharm"},{"key":"685_CR5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.colsurfb.2012.04.027","volume":"97","author":"SS Chalikwar","year":"2012","unstructured":"Chalikwar SS, Belgamwar VS, Talele VR, Surana SJ, Patil MU (2012) Formulation and evaluation of nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system. Colloid Surf B 97:109\u2013116","journal-title":"Colloid Surf B"},{"key":"685_CR6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.addr.2011.03.011","volume":"63","author":"HK Chan","year":"2011","unstructured":"Chan HK, Kwok PC (2011) Production methods for nanodrug particles using the bottom-up approach. Adv Drug Deliv Rev 63:406\u2013416","journal-title":"Adv Drug Deliv Rev"},{"key":"685_CR7","first-page":"2943","volume":"9","author":"I Elsayed","year":"2014","unstructured":"Elsayed I, Abdelbary AA, Elshafeey AH (2014) Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers. Int J Nanomed 9:2943\u20132953","journal-title":"Int J Nanomed"},{"key":"685_CR8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijpharm.2013.06.039","volume":"454","author":"MS Freag","year":"2013","unstructured":"Freag MS, Elnaggar YS, Abdallah OY (2013) Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation. Int J Pharm 454:462\u2013471","journal-title":"Int J Pharm"},{"key":"685_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.colsurfb.2013.01.066","volume":"109","author":"Q Fu","year":"2013","unstructured":"Fu Q, Sun J, Zhang D, Li M, Wang Y, Ling G, Liu X, Sun Y, Sui X, Luo C, Sun L, Han X, Lian H, Zhu M, Wang S, He Z (2013) Nimodipine nanocrystals for oral bioavailability improvement: preparation, characterization and pharmacokinetic studies. Colloid Surf B 109:161\u2013166","journal-title":"Colloid Surf B"},{"key":"685_CR10","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1208\/s12249-013-9995-4","volume":"14","author":"I Ghosh","year":"2013","unstructured":"Ghosh I, Michniak-Kohn B (2013) Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin\u2013a case study. AAPS PharmSciTech 14:1108\u20131117","journal-title":"AAPS PharmSciTech"},{"key":"685_CR11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2011.02.051","volume":"409","author":"I Ghosh","year":"2011","unstructured":"Ghosh I, Bose S, Vippagunta R, Harmon F (2011) Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm 409:260\u2013268","journal-title":"Int J Pharm"},{"key":"685_CR12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3109\/10837450.2012.723720","volume":"18","author":"I Ghosh","year":"2013","unstructured":"Ghosh I, Schenck D, Bose S, Liu F, Motto M (2013) Identification of critical process parameters and its interplay with nanosuspension formulation prepared by top down media milling technology\u2013a QbD perspective. Pharm Dev Technol 18:719\u2013729","journal-title":"Pharm Dev Technol"},{"key":"685_CR14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1208\/s12249-014-0211-y","volume":"16","author":"J Hao","year":"2015","unstructured":"Hao J, Gao Y, Zhao J, Zhang J, Li Q, Zhao Z, Liu J (2015) Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design. AAPS PharmSciTech 16:118\u2013128","journal-title":"AAPS PharmSciTech"},{"key":"685_CR15","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1002\/jps.23267","volume":"101","author":"P Kayaert","year":"2012","unstructured":"Kayaert P, Van den Mooter G (2012a) An investigation of the adsorption of hydroxypropylmethyl cellulose 2910 5\u00a0mPa\u00a0s and polyvinylpyrrolidone K90 around Naproxen nanocrystals. J Pharm Sci 101:3916\u20133923","journal-title":"J Pharm Sci"},{"key":"685_CR16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ejpb.2012.04.020","volume":"81","author":"P Kayaert","year":"2012","unstructured":"Kayaert P, Van Den Mooter G (2012b) Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with naproxen and cinnarizine. Eur J Pharm Biopharm 81:650\u2013656","journal-title":"Eur J Pharm Biopharm"},{"key":"685_CR17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","volume":"62","author":"CM Keck","year":"2006","unstructured":"Keck CM, Muller RH (2006) Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm 62:3\u201316","journal-title":"Eur J Pharm Biopharm"},{"key":"685_CR18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","volume":"59","author":"F Kesisoglou","year":"2007","unstructured":"Kesisoglou F, Panmai S, Wu Y (2007) Nanosizing\u2013oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 59:631\u2013644","journal-title":"Adv Drug Deliv Rev"},{"key":"685_CR19","unstructured":"Kipp J, Joseph CT, Doty MJ, Rebbeck CL (2005) Microprecipitation method for preparing submicron suspensions. U.S. Patent 6,869,617"},{"key":"685_CR20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2014.01.013","volume":"464","author":"S Kumar","year":"2014","unstructured":"Kumar S, Xu X, Gokhale R, Burgess DJ (2014) Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach. Int J Pharm 464:34\u201345","journal-title":"Int J Pharm"},{"key":"685_CR21","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/mp300688t","volume":"10","author":"Y Li","year":"2013","unstructured":"Li Y, Sun S, Chang Q, Zhang L, Wang G, Chen W, Miao X, Zheng Y (2013) A strategy for the improvement of the bioavailability and antiosteoporosis activity of BCS IV flavonoid glycosides through the formulation of their lipophilic aglycone into nanocrystals. Mol Pharm 10:2534\u20132542","journal-title":"Mol Pharm"},{"key":"685_CR22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3109\/10837450.2013.819015","volume":"19","author":"Y Li","year":"2014","unstructured":"Li Y, Wang Y, Yue PF, Hu PY, Wu ZF, Yang M, Yuan HL (2014) A novel high-pressure precipitation tandem homogenization technology for drug nanocrystals production\u2014a case study with ursodeoxycholic acid. Pharm Dev Technol 19:662\u2013670","journal-title":"Pharm Dev Technol"},{"key":"685_CR23","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1021\/la061122t","volume":"22","author":"ME Matteucci","year":"2006","unstructured":"Matteucci ME, Hotze MA, Johnston KP, Williams RO 3rd (2006) Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir 22:8951\u20138959","journal-title":"Langmuir"},{"key":"685_CR24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2008.12.030","volume":"371","author":"PR Mishra","year":"2009","unstructured":"Mishra PR, Al Shaal L, Muller RH, Keck CM (2009) Production and characterization of Hesperetin nanosuspensions for dermal delivery. Int J Pharm 371:182\u2013189","journal-title":"Int J Pharm"},{"key":"685_CR25","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.2174\/1381612811319350003","volume":"19","author":"K Moribe","year":"2013","unstructured":"Moribe K, Ueda K, Limwikrant W, Higashi K, Yamamoto K (2013) Nano-sized crystalline drug production by milling technology. Curr Pharm Des 19:6246\u20136258","journal-title":"Curr Pharm Des"},{"key":"685_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2004.09.007","volume":"288","author":"M Perrut","year":"2005","unstructured":"Perrut M, Jung J, Leboeuf F (2005) Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I: micronization of neat particles. Int J Pharm 288:3\u201310","journal-title":"Int J Pharm"},{"key":"685_CR27","unstructured":"Petersen R (2010) Nanocrystals for use in topical cosmetic formulations and method of production thereof. U.S. Patent 20,100,047,297 (A1)"},{"key":"685_CR28","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","volume":"298","author":"JD Pickard","year":"1989","unstructured":"Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, Humphrey PR, Lang DA, Nelson R, Richards P (1989) Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 298:636\u2013642","journal-title":"BMJ"},{"key":"685_CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2009.05.062","volume":"379","author":"X Pu","year":"2009","unstructured":"Pu X, Sun J, Wang Y, Wang Y, Liu X, Zhang P, Tang X, Pan W, Han J, He Z (2009) Development of a chemically stable 10-hydroxycamptothecin nanosuspensions. Int J Pharm 379:167\u2013173","journal-title":"Int J Pharm"},{"key":"685_CR30","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","volume":"3","author":"BE Rabinow","year":"2004","unstructured":"Rabinow BE (2004) Nanosuspensions in drug delivery. Nat Rev Drug Discov 3:785\u2013796","journal-title":"Nat Rev Drug Discov"},{"key":"685_CR31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s13318-013-0158-5","volume":"39","author":"BP Sahu","year":"2014","unstructured":"Sahu BP, Das MK (2014) Preparation and in vitro\/in vivo evaluation of felodipine nanosuspension. Eur J Drug Metab Pharmacokinet 39:183\u2013193","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"685_CR32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12247-014-9189-y","volume":"9","author":"SR Shah","year":"2014","unstructured":"Shah SR, Parikh RH, Chavda JR, Sheth NR (2014) Glibenclamide nanocrystals for bioavailability enhancement: formulation design, process optimization, and pharmacodynamic evaluation. J Pharma Innov 9:227\u2013237","journal-title":"J Pharma Innov"},{"key":"685_CR33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijpharm.2010.07.044","volume":"399","author":"R Shegokar","year":"2010","unstructured":"Shegokar R, Muller RH (2010) Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm 399:129\u2013139","journal-title":"Int J Pharm"},{"key":"685_CR34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2013.01.019","volume":"453","author":"B Sinha","year":"2013","unstructured":"Sinha B, Muller RH, Moschwitzer JP (2013) Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int J Pharm 453:126\u2013141","journal-title":"Int J Pharm"},{"key":"685_CR35","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijpharm.2008.03.040","volume":"359","author":"Y Sun","year":"2008","unstructured":"Sun Y, Rui Y, Wenliang Z, Tang X (2008) Nimodipine semi-solid capsules containing solid dispersion for improving dissolution. Int J Pharm 359:144\u2013149","journal-title":"Int J Pharm"},{"key":"685_CR36","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1002\/jps.22587","volume":"100","author":"W Sun","year":"2011","unstructured":"Sun W, Mao S, Shi Y, Li LC, Fang L (2011) Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption. J Pharm Sci 100:3365\u20133373","journal-title":"J Pharm Sci"},{"key":"685_CR37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3109\/03639045.2014.914528","volume":"41","author":"W Sun","year":"2015","unstructured":"Sun W, Ni R, Zhang X, Li LC, Mao S (2015) Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation. Drug Dev Ind Pharm 41:927\u2013933","journal-title":"Drug Dev Ind Pharm"},{"key":"685_CR38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ijpharm.2014.08.017","volume":"474","author":"TT Tran","year":"2014","unstructured":"Tran TT, Tran PH, Nguyen MN, Tran KT, Pham MN, Tran PC, Vo TV (2014) Amorphous isradipine nanosuspension by the sonoprecipitation method. Int J Pharm 474:146\u2013150","journal-title":"Int J Pharm"},{"key":"685_CR39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2013.10.001","volume":"458","author":"L Tu","year":"2013","unstructured":"Tu L, Yi Y, Wu W, Hu F, Hu K, Feng J (2013) Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat. Int J Pharm 458:135\u2013140","journal-title":"Int J Pharm"},{"key":"685_CR40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.07.023","volume":"364","author":"B Eerdenbrugh Van","year":"2008","unstructured":"Van Eerdenbrugh B, Van den Mooter G, Augustijns P (2008) Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm 364:64\u201375","journal-title":"Int J Pharm"},{"key":"685_CR41","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1021\/la9016432","volume":"25","author":"S Verma","year":"2009","unstructured":"Verma S, Huey BD, Burgess DJ (2009) Scanning probe microscopy method for nanosuspension stabilizer selection. Langmuir 25:12481\u201312487","journal-title":"Langmuir"},{"key":"685_CR43","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2007.08.036","volume":"350","author":"R Xiong","year":"2008","unstructured":"Xiong R, Lu W, Li J, Wang P, Xu R, Chen T (2008a) Preparation and characterization of intravenously injectable nimodipine nanosuspension. Int J Pharm 350:338\u2013343","journal-title":"Int J Pharm"},{"key":"685_CR44","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1211\/jpp.60.9.0006","volume":"60","author":"R Xiong","year":"2008","unstructured":"Xiong R, Lu W, Yue P, Xu R, Li J, Chen T, Wang P (2008b) Distribution of an intravenous injectable nimodipine nanosuspension in mice. J Pharm Pharmacol 60:1155\u20131159","journal-title":"J Pharm Pharmacol"},{"key":"685_CR45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejpb.2008.05.001","volume":"70","author":"T Yi","year":"2008","unstructured":"Yi T, Wan J, Xu H, Yang X (2008) A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 70:439\u2013444","journal-title":"Eur J Pharm Biopharm"},{"key":"685_CR46","first-page":"2961","volume":"8","author":"PF Yue","year":"2013","unstructured":"Yue PF, Li Y, Wan J, Wang Y, Yang M, Zhu WF, Wang CH, Yuan HL (2013) Process optimization and evaluation of novel baicalin solid nanocrystals. Int J Pharm 8:2961\u20132973","journal-title":"Int J Pharm"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0685-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-015-0685-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0685-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:57:46Z","timestamp":1559444266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-015-0685-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,19]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["685"],"URL":"https:\/\/doi.org\/10.1007\/s12272-015-0685-5","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"type":"print","value":"0253-6269"},{"type":"electronic","value":"1976-3786"}],"subject":[],"published":{"date-parts":[[2015,11,19]]}}}